Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Penile Neoplasms 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Mycosis Fungoides 1Mouth Neoplasms 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 11Vincristine 9Temozolomide 7Magnetic Resonance Spectroscopy 6Irinotecan 6Filgrastim 6Etoposide 6Doxorubicin 6X-Rays 5Phantoms, Imaging 5Ifosfamide 5Dactinomycin 5cixutumumab 4Vinorelbine 4Specimen Handling 4Sirolimus 4Nuclear Medicine Department, Hospital 4Melphalan 4Gemcitabine 4pegfilgrastim 3palbociclib 3Tacrolimus 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Dexrazoxane 3Biopsy 3ulixertinib 2tipifarnib 2thymoglobulin 2temsirolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Rhabdomyosarcoma × Indinavir × Clear all
NCT00001566 2012-06-15

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
42 enrolled 16 charts
Sarcoma

Rhabdomyosarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡